Market Tracker

10/21 11:10am ET

Gilead Sciences Inc (NASDAQ:GILD)

104.39
Real-Time Quote
 +2.18 / +2.13%
Today’s Change
63.50
Today|||52-Week Range
110.64
+39.00%
Year-to-Date

Today’s Trading

Previous close102.21
Today’s open104.05
Day’s range103.46 - 105.00
Volume3,975,498
Average volume (3 months)14,491,115
Market cap$154.5B
Dividend yield--
Data as of 10:55am ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+10.37%
Earnings growth (this year)+293.88%
Earnings growth (next 5 years)+18.05%
Revenue growth (last year)+16.72%
P/E ratio23.5
Price/Sales10.23
Price/Book13.79

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen Inc+2.00+1.45%
BIIBBiogen Idec Inc+10.61+3.41%
BAXBaxter International...-0.01-0.01%
GEVASynageva BioPharma C...-0.22-0.30%
Data as of 11:09am ET, 10/21/2014

Financials

Last reporting dateOctober 21, 2014
EPS forecast (this quarter)$1.92
Annual revenue (last year)$11.2B
Annual profit (last year)$3.1B
Net profit margin27.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts